Diabetic Retinopathy and Subclinical Signs of Disease Transition (DIRECTION)
Principal Investigator
David MaberleyOverview
Body Locations and Systems
Diabetic Eye ProblemsDisorders and Conditions
Diabetes ComplicationsClinicalTrials.gov#
NCT03635671Status
RecruitingStudy Start/End
Jan 9, 2019 to Jul 31, 2020Locations
Vancouver General HospitalName/Title
Sonja Karst, Post Doctoral FellowPhone
604-875-5475Email Address
sonja.karst@ubc.caPurpose of Study
The purpose of this study is to quantify and follow the retinal layer thickness and capillary density in patients that are in a critical period of disease transition to better understand the process of diabetic retinopathy.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.